Home › Research › Tau biomarkers
Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain
Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttilä T.. Archives of neurology, 2009-03-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Background There is a clear need to develop an objective diagnostic test for Alzheimer disease (AD). Changes in the levels of cerebrospinal fluid (CSF) tau protein and beta-amyloid 42 (Abeta42) peptide in patients with AD have been well documented, but the relationship between these biomarkers and neuropathologic changes in the brain is not established. Objective To study the relationship between antemortem CSF biomarker levels and Alzheimer-type neuropathologic changes in the brain.
What this study adds
Evidence grade: Low
This is a cross-sectional study of 123 participants. CSF changes in Alzheimer's were already "well documented", but the authors noted that how they relate to changes in the brain itself "is not established". Reported effect size: 91.6%; 85.7%; 90.2%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Tapiola, T., Alafuzoff, I., Herukka, S. K., Parkkinen, L., Hartikainen, P., Soininen, H., et al. (2009). Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Archives of neurology. https://doi.org/10.1001/archneurol.2008.596
Vancouver
Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, et al. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Archives of neurology. 2009. doi:10.1001/archneurol.2008.596. PMID: 19273758.
BibTeX
@article{tapiola2009-19273758,
author = {Tapiola, T. and Alafuzoff, I. and Herukka, S. K. and Parkkinen, L. and Hartikainen, P. and Soininen, H. and Pirttilä, T.},
title = {{Cerebrospinal fluid beta-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain}},
journal = {Archives of neurology},
year = {2009},
doi = {10.1001/archneurol.2008.596},
pmid = {19273758},
url = {https://doi.org/10.1001/archneurol.2008.596}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Changes in the levels of cerebrospinal fluid (CSF) tau protein and beta-amyloid 42 (Abeta42) peptide in patients with AD have been well documented, but the relationship between these biomarkers and neuropathologic changes in the brain is not established.
- Objective To study the relationship between antemortem CSF biomarker levels and Alzheimer-type neuropathologic changes in the brain.
- Design Cross-sectional study to correlate levels of CSF Abeta42, total tau, and phosphorylated tau protein with neuropathologic changes in the brain.
- Patients The study included 123 patients (79 with clinically diagnosed AD, 29 with other dementia, and 15 with other neurologic disease).
Why it matters
CSF changes in Alzheimer's were already "well documented", but the authors noted that how they relate to changes in the brain itself "is not established". This cross-sectional study of 123 patients (79 clinically diagnosed with Alzheimer's, 29 with other dementias, 15 with other neurological diseases) compared spinal-fluid Aβ42, total tau and phosphorylated tau measured in life with Alzheimer-type changes in the brain. The summary we hold ends before the results, so check the original paper for what it found. As a measurement study, it says nothing about treatment or prevention.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Study designcross-sectional
- Participants123
- Effect size91.6%; 85.7%; 90.2%
- Evidence strengthLow
How this study scored 60/100
Published in a peer-reviewed journal, and it is a snapshot of people at one point in time. Scored zero for randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Archives of neurology) |
| Journal's citation record | 3 / 4 | Archives of Neurology: journal h-index 353 (OpenAlex, 2026-10-29) |
| Study design | 4 / 12 | A snapshot of people at one point in time |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2009 — within 20 year(s) of the newest study here |
| Sample size | 2 / 4 | 123 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 899 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 47.3 citations a year over 19 year(s) since 2009 |
| Impact for its field and year | 5 / 6 | Cited 28.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 4 / 6 | Cited by 83 other studies in this library |
| Still being cited | 3 / 4 | Cited 89 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Tuula Pirttilä: h-index 53 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Kuopio University Hospital: institution h-index 529 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 19273758) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 60 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1001/archneurol.2008.596
- PubMed: 19273758
- Original source →
- Free full text: Archives of Neurology →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 17.
Later studies that cite this one
83 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.